Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 906
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +5.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (459)

clinicaltrialsPublishedShowing 1–50 of 265 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07691762	A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma	not yet recruiting	Phase 3	690	Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT07715903	Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy	not yet recruiting	Phase 1	20	National Cancer Institute (NCI)NIH	1